Neurotronic Presents Groundbreaking Clinical Findings for Diabetes and Hypertension Treatment#United_States#San_Francisco#Medical_Trials#Neurotronic#Neuviant
Neurotronic Presents Groundbreaking Clinical Findings for Diabetes and Hypertension Treatment
Neurotronic, Inc. reveals the first clinical outcomes from their innovative Neuviant therapy for type 2 diabetes and hypertension, showcasing promising results.
third-news.com
October 24, 2025 at 12:08 PM
Neurotronic Presents Groundbreaking Clinical Findings for Diabetes and Hypertension Treatment#United_States#San_Francisco#Medical_Trials#Neurotronic#Neuviant
Investors of Anika Therapeutics Face Uncertainty Amid Legal Investigations#USA#New_York#Pomerantz_LLP#Medical_Trials#Anika_Therapeutics
Investors of Anika Therapeutics Face Uncertainty Amid Legal Investigations
Pomerantz Law Firm is investigating claims from investors of Anika Therapeutics after a significant drop in stock price post-trial results.
third-news.com
August 27, 2025 at 2:25 PM
Investors of Anika Therapeutics Face Uncertainty Amid Legal Investigations#USA#New_York#Pomerantz_LLP#Medical_Trials#Anika_Therapeutics
Lipogems Celebrates Milestone in ARISE I Knee Osteoarthritis Clinical Trial Completion#United_States#Atlanta#Osteoarthritis#Lipogems#Medical_Trials
Lipogems Celebrates Milestone in ARISE I Knee Osteoarthritis Clinical Trial Completion
Lipogems proudly announces the successful completion of the ARISE I clinical trial for knee osteoarthritis, paving the way for innovative treatments.
third-news.com
May 7, 2025 at 1:48 PM
Lipogems Celebrates Milestone in ARISE I Knee Osteoarthritis Clinical Trial Completion#United_States#Atlanta#Osteoarthritis#Lipogems#Medical_Trials